Comparison of modified agonist, mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve

J Int Med Res. 2018 Jun;46(6):2327-2337. doi: 10.1177/0300060518770346. Epub 2018 Apr 25.

Abstract

Objective To compare the efficacy of three protocols for ovarian stimulation in patients with diminished ovarian reserve during in vitro fertilization (IVF) treatment. Methods This prospective randomized study enrolled patients with diminished ovarian reserve who underwent cycles of IVF or intracytoplasmic sperm injection. The patients were randomly divided into three groups: a modified gonadotrophin releasing hormone (GnRH) agonist protocol (group A); (ii) a mild stimulation protocol (group B); or (iii) an antagonist protocol (group C). Demographic characteristics, clinical variables and pregnancy outcomes were compared between the groups. Results A total of 116 patients were enrolled in the study: 54 in group A, 52 in group B and 60 in group C. Group B (32.69%) had a significantly higher cycle cancellation rate compared with groups A (11.11%) and C (16.67%). The early abortion rate of group C (44.44%) was significantly higher than group A (12.50%), but not significantly different from group B (16.67%). There were no significant differences in the clinical pregnancy rates and live birth rates among the three groups. Conclusion A modified GnRH agonist protocol achieved a comparable pregnancy rate to those of the mild stimulation protocol and antagonist protocol, whilst having lower cycle cancellation and early abortion rates.

Keywords: Gonadotrophin releasing hormone agonist; antagonist; human menopausal gonadotrophin; in vitro fertilization; ovarian reserve.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Clinical Protocols*
  • Female
  • Fertility Agents, Female / administration & dosage*
  • Fertilization in Vitro / methods*
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Gonadotropin-Releasing Hormone / agonists
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors
  • Humans
  • Letrozole / administration & dosage
  • Luteolytic Agents / administration & dosage
  • Male
  • Menotropins / administration & dosage
  • Ovarian Follicle / diagnostic imaging
  • Ovarian Follicle / drug effects
  • Ovarian Reserve / drug effects*
  • Ovulation Induction / methods*
  • Pregnancy
  • Pregnancy Rate
  • Prospective Studies
  • Sperm Injections, Intracytoplasmic / methods
  • Treatment Outcome
  • Triptorelin Pamoate / administration & dosage

Substances

  • Fertility Agents, Female
  • Luteolytic Agents
  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
  • Menotropins
  • Letrozole
  • cetrorelix